ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,707Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 2094

$779K Total Retail Price of All Prescriptions

Rank: 190 out of 2094

456 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 10,099 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
MELOXICAM 414 350 1 49
METFORMIN HCL 379 287 2 8
ATORVASTATIN CALCIUM 361 295 3 5
ZOLPIDEM TARTRATE 317 256 4 14
SIMVASTATIN 301 240 5 1
LEVOTHYROXINE SODIUM 292 239 6 3
OMEPRAZOLE 274 225 7 4
NEXIUM 253 229 8 16
AMLODIPINE BESYLATE 251 230 9 2
METOPROLOL TARTRATE 249 176 10 10
ENALAPRIL MALEATE 248 200 11 25
FUROSEMIDE 215 187 12 6
LOSARTAN POTASSIUM 201 146 13 17
FLUTICASONE PROPIONATE 184 134 14 41
CLOPIDOGREL 173 147 15 22
FAMOTIDINE 171 136 16 34
GLIMEPIRIDE 162 139 17 31
JANUVIA 157 128 18 35
PRAVASTATIN SODIUM 153 117 19 18
METOPROLOL SUCCINATE 146 123 20 9
CRESTOR 146 118 20 15
DIOVAN 143 113 22 13
MECLIZINE HCL 132 111 23 103
DIOVAN HCT 132 106 23 28
TRAMADOL HCL 132 107 23 33
AZITHROMYCIN 130 99 26 27
EVISTA 124 117 27 131
PANTOPRAZOLE SODIUM 115 93 28 37
GLYBURIDE-METFORMIN HCL 114 90 R 29 94
SINGULAIR 112 81 30 64
LISINOPRIL 112 102 30 7
PROAIR HFA 110 85 32 45
CARVEDILOL 110 100 32 19
TRAMADOL HCL-ACETAMINOPHEN 103 70 34 100
LEVOCETIRIZINE DIHYDROCHLORIDE 103 79 34 169
ADVAIR DISKUS 102 87 36 36
PLAVIX 102 88 36 38
ALENDRONATE SODIUM 100 64 38 30
ENDOCET 98 63 S2 39 88
GABAPENTIN 98 70 39 23
PREDNISONE 97 91 41 54
OXYCODONE-ACETAMINOPHEN 96 85 S2 42 40
DONEPEZIL HCL 90 79 43 20
ATENOLOL 90 73 43 21
LIPITOR 87 79 45 39
LOSARTAN-HYDROCHLOROTHIAZIDE 84 71 46 52
LOVAZA 84 68 46 53
SERTRALINE HCL 83 70 48 26
MONTELUKAST SODIUM 82 63 49 128
WARFARIN SODIUM 81 68 50 11
DEXILANT 78 69 51 124
POTASSIUM CHLORIDE 76 59 52 24
HYDROCHLOROTHIAZIDE 76 68 52 12
CIPROFLOXACIN HCL 73 55 54 81
MIRTAZAPINE 71 66 55 43
GLIPIZIDE 70 65 56 82
RANITIDINE HCL 67 52 57 80
CYCLOBENZAPRINE HCL 61 48 R 58 115
LANTUS SOLOSTAR 59 47 59 76
POLYETHYLENE GLYCOL 3350 58 52 60 75
AMLODIPINE BESYLATE-BENAZEPRIL 58 57 60 58
JANUMET 55 39 62 86
INSULIN SYRINGE 54 33 63 143
TAMSULOSIN HCL 52 29 64 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.